Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
And they are holding metal they mine, not selling. If more did this it would be a game changer
Go get em boys
If I had a nickel for each time I have read it’s bottom, I could buy a few shares of this stock. Selling million shares each day. We will know when it stops. If it ever does
Mudrick has sold 3 sets, including 12/28. Check out website openinsider.com. Look up amc ticker. Sold just under 10mil shares so far
I have options for $2.50 expire in April so I’m excited for the future
Seeking alpha states a licensing deal expected
Now it seems the volume makes sense. News out
I’m not saying it won’t dump over time as I understand how volatile these stocks are. But all that volume was astonishing for sure
Dozens and dozens of shares “dumping”
Congrats hope you made some cash flow
Setting up great base for more forward momentum
Looking good.
Ton of shares being bought. Slow grind good.
Is this a no brainer here? One announcement to shut down production makes for quick reversal? I’m simply speechless
ReWalk Robotics Reports Second Quarter 2018 Financial Results
Source: GlobeNewswire Inc.
— Total revenue of $1.8 million during the second quarter of 2018 —
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or “the Company”) today announced its financial results for the three- and six-months ended June 30, 2018.
Highlights of and subsequent to the second quarter include:
Total revenue for the second quarter of 2018 was $1.8 million compared to $1.6 million in the prior quarter;
21 units were placed during the second quarter of 2018;
The U.S. Department of Veterans Affairs (“VA”) updated its national policy to provide expanded access to ReWalk exoskeletons with additional VA sites and also including private rehabilitation clinics through the Veterans Choice Program;
ReWalk received the first tranche of $5 million as part of a $20 million investment agreement with Timwell Corporation Limited, a Hong Kong entity, following shareholder approval;
All five leading stroke rehabilitation centers began enrolling patients in ReWalk’s ReStore clinical study;
ReWalk extended its agreement with the Wyss Institute at Harvard University to June 2022 to complete additional research programs for its groundbreaking soft exo-suit; and
ReWalk Personal 6.0 exoskeleton added to the official German list of medical aids, becoming the first exoskeleton device included in the list.
“With several catalysts to drive growth in the sales of ReWalk Personal systems and a significant opportunity to deliver longer term value with our Restore technology, we believe we have a solid platform for growth. The VA Choice Program substantially broadens the geographic coverage area for veterans to the 137 VA and private ReWalk certified training centers across the U.S., which we believe will result in more veterans procuring ReWalk systems. And, with the addition of a formal reimbursement code in Germany, we expect to see faster processing times and additional referrals come through in the months ahead. Our Restore clinical study is underway at five of the leading stroke rehabilitation centers in the country and we are planning a mid-2019 commercial launch of the Restore, pending CE and FDA clearance,” stated Larry Jasinski, Chief Executive Officer of ReWalk.
Second Quarter 2018 Financial Results
Total revenue was $1.8 million for the second quarter of 2018, compared to $1.6 million in the first quarter of 2018 and $2.0 million during the prior year quarter. 21 ReWalk systems were placed during the second quarter of 2018, compared to 23 ReWalk systems placed in the prior quarter and 31 systems in the prior year period. 13 systems were placed in the U.S. and 8 were placed in our direct markets in Europe.
Gross margin improved to 43% during the second quarter of 2018 compared to 37% in the second quarter of 2017, primarily attributable to sales mix and lower product costs.
Total operating expenses in the second quarter of 2018 were $6.0 million compared to $6.1 million in the prior year period.
Net loss was $5.8 million for the second quarter of 2018 compared to a net loss of $6.3 million in the second quarter of 2017. Non-GAAP net loss for the first quarter was $4.7 million compared with a non-GAAP net loss of $4.9 million in the second quarter of 2017. A reconciliation of net loss to non-GAAP net loss is included at the end of this press release.
Liquidity
As of June 30, 2018, ReWalk had $9.1 million in cash on its balance sheet.
Guidance
The Company is updating its full year 2018 revenue guidance and now expects revenues at the lower end of its previously announced range of $9.0 to $11.0 million, depending on timing of reimbursement coverage.
Conference Call
ReWalk management will host its second quarter 2018 conference call as follows:
Date Tuesday, August 14, 2018
Time 8:30 AM EDT
Telephone U.S: (844) 423-9889
International: (716) 247-5804
Israel: 18 09 31 53 62
Access code 4694309
Webcast (live, listen-only and archive) www.rewalk.com under the “Investors” section.
A telephone replay will be available shortly after the completion of the call for two weeks at (855) 859-2056 (U.S.) or (404) 537-3406 (International). The passcode for the replay is 4694309.
About ReWalk Robotics Ltd.
ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke. ReWalk’s mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies. Founded in 2001, ReWalk has headquarters in the U.S., Israel and Germany. For more information on the ReWalk systems, please visit www.rewalk.com.
ReWalk® is a registered trademark of ReWalk Robotics Ltd. in Israel.
Forward-Looking Statements
In addition to historical information, this press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the U.S. Securities Act of 1933, and Section 21E of the U.S. Securities Exchange Act of 1934. Such forward-looking statements may include projections regarding ReWalk’s future performance and, in some cases, may be identified by words like “anticipate,” “assume,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “future,” “will,” “should,” “would,” “seek” and similar terms or phrases. The forward-looking statements contained in this press release are based on management’s current expectations, which are subject to uncertainty, risks and changes in circumstances that are difficult to predict and many of which are outside of ReWalk’s control. Important factors that could cause ReWalk’s actual results to differ materially from those indicated in the forward-looking statements include, among others: ReWalk’s expectations regarding future growth, including its ability to increase sales in its existing geographic markets, and to expand to new markets and achieve its planned expense reductions; the conclusion of ReWalk’s management and the previous opinion of ReWalk’s auditors, that there are substantial doubts as to ReWalk’s ability to continue as a going concern; ReWalk’s ability to maintain and grow its reputation and the market acceptance of its products; ReWalk’s ability to achieve reimbursement from third-party payors for its products; ReWalk’s expectations as to its clinical research program and clinical results; ReWalk’s expectations as to the results of, and the Food and Drug Administration’s potential regulatory developments with respect to, ReWalk’s mandatory post-market 522 surveillance study; the outcome of ongoing shareholder class action litigation relating to ReWalk’s initial public offering; ReWalk’s ability to repay its secured indebtedness; ReWalk’s ability to improve its products and develop new products; ReWalk’s ability to maintain adequate protection of its intellectual property and to avoid violation of the intellectual property rights of others; ReWalk’s ability to gain and maintain regulatory approvals; ReWalk’s ability to secure capital from its equity and debt financings in light of limitations under its Form S-3, the price range of its ordinary shares and conditions in the financial markets, and the risk that such financings may dilute ReWalk’s shareholders or restrict its business; ReWalk’s ability to use effectively the proceeds of offerings of securities; ReWalk’s ability to maintain relationships with existing customers and develop relationships with new customers; the impact of the market price of ReWalk’s ordinary shares on the determination of whether ReWalk is a passive foreign investment company; ReWalk’s ability to maintain compliance with the continued listing requirements of the NASDAQ Capital Market and the risk that its ordinary shares will be delisted if it cannot do so; ReWalk’s compliance with medical device reporting regulations to report adverse events involving its products and the potential impact of such adverse events on ReWalk’s ability to market and sell its products; the risk of substantial dilution resulting from the issuance to Timwell; the significant voting power and de facto voting control Timwell may acquire; the risk that the remaining Timwell issuances will fail to close and the China joint venture will not form; and other factors discussed under the heading “Risk Factors” in ReWalk’s Annual Report on Form 10-K for the fiscal year ended December 31, 2017 filed with the Securities and Exchange Commission and other documents subsequently filed with or furnished to the SEC. Any forward-looking statement made in this press release speaks only as of the date hereof. Factors or events that could cause ReWalk’s actual results to differ from the statements contained herein may emerge from time to time, and it is not possible for ReWalk to predict all of them. Except as required by law, ReWalk undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.
Non-GAAP Financial Measures
To supplement its consolidated financial statements, which are prepared and presented in accordance with U.S. Generally Accepted Accounting Principles (GAAP), ReWalk believes that the use of non-GAAP accounting measures, including non-GAAP net loss, is helpful to its investors. These measures, which the Company refers to as non-GAAP financial measures, are not prepared in accordance with GAAP.
For the three- and six-months ended June 30, 2018 and 2017, non-GAAP net loss is calculated as GAAP net loss excluding (i) non-cash share-based compensation expense, (ii) depreciation and (iii) non-cash financial expenses.
Because of varying available valuation methodologies, subjective assumptions, and the variety of equity instruments that can impact a company’s non-cash expenses, ReWalk believes that providing non-GAAP financial measures that exclude non-cash share-based compensation expense, depreciation and non-cash financial (income) expenses allows for more meaningful comparisons between operating results from period to period. Each of the Company’s non-GAAP financial measures is an important tool for financial and operational decision-making and for the Company’s evaluation of its operating results over different periods of time. The non-GAAP financial data are not measures of the Company’s financial performance under U.S. GAAP, and should not be considered as alternatives to operating loss or net loss or any other performance measures derived in accordance with GAAP. Non-GAAP financial measures may not provide information that is directly comparable to that provided by other companies in ReWalk’s industry, as other companies in the industry may calculate non-GAAP financial results differently, particularly related to non-recurring, unusual items. In addition, there are limitations in using non-GAAP financial measures because the non-GAAP financial measures are not prepared in accordance with GAAP, may be different from non-GAAP financial measures used by other companies and exclude expenses that may have a material impact on the Company’s reported financial results. Further, share-based compensation expense has been, and will continue to be for the foreseeable future, a significant recurring expense in the Company’s business and an important part of the compensation provided to its employees. The presentation of non-GAAP financial information is not meant to be considered in isolation or as a substitute for the directly comparable financial measures prepared in accordance with GAAP. ReWalk urges investors to review the reconciliation of the Company’s non-GAAP financial measures to the comparable GAAP financial measures included below, and not to rely on any single financial measure to evaluate the Company’s business.
Investor Contact:
Lisa M. Wilson
President
In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com
(tables follow)
ReWalk Robotics Ltd.
Condensed Consolidated Statements of Operations
In thousands except per share data
(unaudited)
Three Months Ended Six months ended
June 30, June 30,
2018 2017 2018 2017
Revenue $ 1,770 $ 2,007 $ 3,349 $ 4,506
Cost of revenues 1,003 1,266 1,900 2,716
Gross profit 767 741 1,449 1,790
Operating expenses:
Research and development, net 1,897 1,385 4,048 2,815
Sales and marketing 1,925 2,873 4,261 6,006
General and administrative 2,221 1,850 4,258 3,991
Total operating expenses 6,043 6,108 12,567 12,812
Operating loss (5,276 ) (5,367 ) (11,118 ) (11,022 )
Loss on extinguishment of debt - 313 - 313
Financial expenses, net 522 633 1,007 1,364
Loss before income taxes (5,798 ) (6,313 ) (12,125 ) (12,699 )
Income taxes (tax benefit) - (4 ) (1 ) 10
Net loss $ (5,798 ) $ (6,309 ) $ (12,124 ) $ (12,709 )
Net loss per ordinary share, basic and diluted $ (0.18 ) $ (0.37 ) $ (0.39 ) $ (0.75 )
Weighted average number of shares used in computing net loss per ordinary share, basic and diluted 32,772,061 17,218,154 31,413,229 16,837,903
Reconciliation of GAAP to Non-GAAP net loss
Net loss $ (5,798 ) $ (6,309 ) $ (12,124 ) $ (12,709 )
Non-cash share based compensation expense 1,023 847 1,819 1,698
Depreciation 116 177 229 357
Non-cash financial expenses - 346 - 379
Non-GAAP net loss $ (4,659 ) $ (4,939 ) $ (10,076 ) $ (10,275 )
ReWalk Robotics Ltd.
Condensed Consolidated Balance Sheets
In thousands
June 30, December 31,
2018 2017
Assets Unaudited Audited
Current assets
Cash and cash equivalents $ 9,094 $ 14,567
Trade receivable, net 1,857 1,103
Prepaid expenses and other current assets 1,238 1,625
Inventories 3,016 3,643
Total current assets 15,205 20,938
Other long-term assets 1,058 1,085
Property and equipment, net 762 840
Total assets $ 17,025 $ 22,863
Liabilities and equity
Current liabilities
Current maturities of long term loan $ 6,441 $ 6,441
Trade payables 2,957 1,811
Other current liabilities 1,673 1,475
Total current liabilities 11,071 9,727
Long term loan 6,640 8,911
Other long-term liabilities 578 518
Shareholders' equity (1,264 ) 3,707
Total liabilities and equity $ 17,025 $ 22,863
ReWalk Robotics Ltd.
Condensed Consolidated Statements of Cash Flows
In thousands
(unaudited)
Six months ended
June 30,
2018 2017
Net cash used in operating activities $ (9,068 ) $ (11,196 )
Net cash used in investing activities (3 ) (22 )
Net cash provided by financing activities 3,579 3,830
Decrease in cash and cash equivalents (5,492 ) (7,388 )
Cash and cash equivalents at beginning of period 15,423 24,498
Cash and cash equivalents at end of period $ 9,931 $ 17,110
ReWalk Robotics Ltd.
Revenue and Units Placed by Region and Product
In thousands except units
(unaudited)
Three Months Ended Six months ended
June 30, June 30,
2018 2017 2018 2017
Revenue:
United States $ 1,091 $ 1,342 $ 2,269 $ 3,441
Europe 673 665 1,014 1,065
Asia Pacific 6 - 8 -
Latin America - - 58 -
Total Revenues $ 1,770 $ 2,007 $ 3,349 $ 4,506
Units Placed:
United States 13 17 27 43
Europe 8 14 16 25
Latin America - - 1 -
Total Units Placed 21 31 44 68
Revenue:
Personal units revenue $ 1,770 $ 1,903 $ 3,269 $ 4,326
Rehabilitation units revenue - 104 80 180
Total Revenue $ 1,770 $ 2,007 $ 3,349 $ 4,506
Units Placed:
Personal units placed 21 30 43 66
Rehabilitation units placed - 1 1 2
Total Units Placed
From CBS Sunday Morning episode 8/12/18
https://www.cbsnews.com/news/robotic-exoskeletons-helping-paraplegics-walk-again/
Hey all, new here last few days. Saw a report on this tech on tv the other day and just saw a quick preview as to Sunday morning cbs news gonna talk about robots helping people move again. Got into both Stocks you guys have been talking about. Very excited!
What is the best gold coin for the money in your opinion?
Thanks for future responses
Good old fashion short squeeze in order!? Or is this so manipulated that can't even happen?
Short squeeze?
Such petty little trades. What's the deal with that
So this ticker Grhhq will go back to GRH or will they make a new one? How soon do we think? Always hoped for great things with this stock. Maybe once again?
Canarc Options FG Gold Property in Central BC from Eureka Resources
Vancouver, Canada –August 25, 2016 – Canarc Resource Corp. (TSX: CCM, OTC-BB: CRCUF, Frankfurt: CAN) (the “Company”) announces the signing of an agreement with Eureka Resources Inc. (TSX-V: EUK) (“Eureka”) which grants Canarc an exclusive option (the “Option”) to acquire up to a 75% interest in the FG Gold Property (the “Property”) located approximately 100 kilometres east of Williams Lake in central British Columbia.
The Agreement
The Option is to be exercised in two stages, with the first stage giving Canarc the right to earn a 51% interest in the Property and the second stage giving Canarc the right to earn an additional 24% interest for a total 75% interest in the Property.
In consideration for the grant of the Option, subject to the approval of the Toronto Stock Exchange (the “TSX”) and the TSX Venture Exchange (the “TSXV”), Canarc will issue to Eureka 250,000 common shares, and participate in Eurkea’s planned private placement, by acquiring 750,000 units of Eureka (each a “unit”) at a price of $0.14 per Unit, at an aggregate cost of $105,000. Each Unit will be comprised of one common share of Eureka and one-half of one common share purchase warrant (a “Warrant”). Each Warrant is exercisable to acquire one additional common share of Eureka at an exercise price of $0.20 for a period of two years after issuance.
Under the terms of the Option Agreement, Canarc can earn the initial 51% interest in the Property by making the following expenditures, share issuances and payments to Eureka:
aggregate property expenditures of $1,500,000, of which at least $500,000 is to be incurred in or before 2017, at least $500,000 is to be incurred during 2018 and the balance is to be incurred during 2019;
share issuances of 250,000 Canarc common shares on or before each of the first, second and third anniversary, for a total of 750,000 Canarc common shares;
annual cash payments equal to 50% of the British Columbia mining exploration tax credit paid to, or credited to the account of, Canarc with respect to the Property (the “METC”) for expenditures incurred by Canarc (to an aggregate maximum of $1,500,000 in expenditures during the first option period) during the prior year.
Upon the exercise of the initial stage of the Option, Canarc will have the option to earn an additional 24% interest for a total 75% interest in the Property by making the following expenditures, share issuances and payments to Eureka:
aggregate expenditures of $1,500,000 between the third anniversary and the fifth anniversaryof the Option Agreement;
share issuances of 750,000 Canarc common shares on or before each of the fourth and fifth anniversary, for a total of 1,500,000 Canarc common shares;
annual cash payments equal to the greater of: (i) $75,000 and (ii) 50% of the METC for expenditures incurred by Canarc (to an aggregate maximum of $1,500,000 in expenditures during the second option period) during the prior year.
Upon exercise of the Option by Canarc, Canarc and Eureka will form a joint venture with respect to the further development of the Property.
Transaction Rationale for Canarc
Canarc entered into the Option Agreement as a result of the following considerations:
Prior third party exploration expenditures on the Property totalling $15 million have yielded a good understanding of the geology of the Property.
Eureka reports an NI 43-101 total measured and Indicated resource of 376,000 ounces gold (“Au”), at an average grade of 0.776 g/t Au, comprised of measured resource of 5,600,000 tonnes at 0.812 Au g/t containing 145,000 oz Au and indicated resource of 9,570,000 tonnes at 0.755 Au g/t containing 231,000 oz Au and an Inferred resource of 634,900 ounces Au at an average grade of 0.718 g/t Au comprised of 27,493,000 tonnes at 0.718 Au g/t. This is considered a historical estimate.
Main zone resource area is open down dip and along strike for expansion, targets are drill ready.
A total of 49,691 meters of exploration drilling in 402 holes has been completed to date.
Recent geophysical and geochemical work has identified several other prospective targets with potential for a significant increase in resources.
Laboratory flotation testing has yielded excellent recoveries.
The Property is easily accessible by paved and all weather logging roads.
The Option diversifies Canarc’s portfolio of BC gold properties.
Exercise of the Option could add substantial additional gold resources at an attractive cost.
1 Details of the gold resource can be found in “NI 43-101 Technical Report, Frasergold Exploration Project, Cariboo Mining Division, dated July 27, 2015” available on SEDAR or at the Eureka’s website. The resource is calculated using a cut-off grade of 0.5 g/t. This resource is an historical estimate and a qualified Canarc person has not done sufficient work to classify the historical estimate as current mineral resources or mineral reserves. A more detailed review of the data used in the resource estimate is needed to verify the historical estimate as current mineral resources or mineral reserves. As a result the historical estimate is not being treated as a current mineral resource.
FG Project
The Property, known as the FG Gold Project, is located in the Cariboo Gold Camp, situated in the historic Quesnel Trough area of central British Columbia and has a long history of continued exploration since the 1970s. A combination of quartz veins and knotted phyllites host gold mineralization containing coarse free gold and finer grained sulphide bearing gold.
The Property consists of 33 contiguous mineral claims totalling 10,400 hectares.
Eureka has held the Property (formerly called Frasergold) since 1982. To date over $15.0 million of exploratory work has been completed on the Property.
Through drilling, soil sampling, induced polarization (“IP”) geophysical surveys and surface exploration mineralization has been defined over a strike length of 3 kilometres, and has indicated potential for additional mineralization that could extend along an interpreted strike length of over 10 kilometers.
An airborne geophysical survey was completed in 2007 covering a large portion of the Eureka Syncline. To cover the area of the airborne survey over the southern limb of the syncline new claims were acquired in June, 2016. A detailed geophysical interpretation was completed on the area of these new claims by SJ Geophysics Ltd. of Surrey, B.C. in July, 2016. The results of this work has revealed three conductive / resistive horizons of the sedimentary package that makes up the favorable lithologies of gold mineralization in the Property Main Zone.
In the Main Zone, the favorable horizon is interpreted at the contact of the upper resistive zone (Knotted phyllite) and the middle conductive zone (black banded phyllite). This same sequence appears at elevations ranging 1700 – 2000 meters (asl) at the South Limb. Only limited prospecting by geochemistry has been completed in this area of the Property.
In July 2016 soil sampling was completed collecting 114 samples in the area of the northwest extension referred to as the northwest “offset” zone. Mapping, sampling and prospecting the “offset” zone was also completed to note similar lithologies to the Main Zone. Results indicate a strong correlation of gold anomalies in soil to the favorable electromagnetic horizon. Soil sample assays ranged from <5 ppb (detection limit) to 1100 ppb gold, the high value coinciding with the interpreted offset zone.
Plans
Prior to conducting additional fieldwork, Canarc plans to complete a detailed review of the historic exploration information and results in order to define the priority targets for the next exploration program.
A priority target will be follow-up work to test the recently delineated targets in the northwest extension “offset” area. This would require a minimum of five diamond drill holes, each 200 – 300 meters in length, and totaling 1,250 meters.
The transaction is subject to TSX and TSXV approvals.
Qualified Person
Garry Biles, P. Eng, President & COO of Canarc, is the Qualified Person who reviewed and approved the contents of this news release.
Catalin Chiloflischi”
____________________
Catalin Chiloflischi, CEO
CANARC RESOURCE CORP.
About Canarc Resource Corp. - Canarc is a growth-oriented, gold exploration and mining Company listed on the TSX (CCM) and the OTC-BB (CRCUF). The Company is currently focused on acquiring operating, development stage and advanced exploration gold mines or properties in the Americas and further advancing its gold properties in north and central BC.
For More Information - Please contact: ?
Catalin Chiloflischi, CEO
Toll Free: 1-877-684-9700?Tel: (604) 685-9700?Fax: (604) 685-9744?
Email: catalin@canarc.net ?Website: www.canarc.net
Well that was an interesting day. Good thing I had stop loss in at 104. I did not see that coming. I shall look to re-enter after a few days. Lord that hurt my heart to see this. Brass balls
I also thought I heard on CNBC of some refineries in some areas were down and could come online anytime. Which would put further pressure on crude?
Ok. Been paying some attention to posts. I get the feeling we have room to go. I can't trade tomorrow until the afternoon. Is it safe to sit in these etfs overnight? Thinking about taking half off the table tonight. Any thoughts
First time Wti trader. Holy shit this takes brass balls. The swings
Canarc Retains Gordon Neal for Corporate Development
Vancouver, Canada – August 10, 2016 – Canarc Resource Corp. (TSX: CCM, OTC-BB: CRCUF, Frankfurt: CAN) is pleased to announce that it has retained Gordon Neal as Consultant, Corporate Development in order to assist the company with its corporate development, growth strategy and market presence.
Mr. Neal was previously the Vice President of Corporate Development for MAG Silver Corp for over 8 years and played a key role in Mag Silver’s significant growth during that time. During his tenure, Mag Silver’s share price grew from about 50 cents to over $16 per share. Gord has more than 25 years of experience in corporate development, capital markets, financing and marketing.
Prior to Mag Silver, he managed Neal McInerney Investor Relations, his clients included several major Canadian corporations and he was instrumental in facilitating more than $4 billion in debt and equity financings. His company grew to become the second largest full service Investor Relations firm in Canada with offices in Vancouver, Toronto and Los Angeles.
Mr. Catalin Chiloflischi, Canarc’s CEO, stated:
“I am pleased to welcome Gord to our team as we prepare Canarc for a new phaseofgrowth. His extensive experience and past success should complement our existing skill sets well. Canarc is now focused on acquiring gold-silver resource projects with expansion potential and gold-silver mining projects with production potential in the Americas. The Company is well funded with over $12 million cash and marketable securities as we embark on an ambitious new growth plan.”
“Catalin Chiloflischi”
____________________
Catalin Chiloflischi, CEO
CANARC RESOURCE CORP.
FOR MORE INFORMATION:
Catalin Chiloflischi, CEO
Toll Free: 1-877-684-9700 Tel: (604) 685-9700 Fax: (604) 685-9744
Email: info@canarc.net Website: www.canarc.net
About Canarc Resource Corp. - Canarc is a growth-oriented, gold exploration and mining company listed on the TSX (CCM) and the OTC-BB (CRCUF). The Company is currently focused on acquiring gold-silver resource projects with expansion potential and gold-silver mining projects with production potential in the Americas. Canarc is also working with a partner to advance its 1.1 million oz, high grade, underground, New Polaris gold mine project in British Columbia to the feasibility stage.
BOE cut rate. Added stimulus. Has more room for stimulus. Yes dollar is reacting but so will metals. Economy here is "good" but this is a global issue. I think stimulus here after election
Nice action lately. Hard time telling if it's following Endevour up or metals. Either way it's moving good. Gltya
Let's break the 52 week high
Very impressed with silver. Gets knocked down only to slowly head back up. Now let's bust through and hold above 20.50 spot
The real question is whether or not this is trading at its present value or below it. With properties cash and stock on hand, shouldn't this be higher than .07?
Looks like they have sold some shares recently. With this update I can't get a feel for whether we will see something soon or if it will be awhile. Can't imagine they will wait much longer than July though. Jmho
Saw this article the other day. New Polaris is nearby.
http://www.businessinsider.com/billions-dollars-gold-and-silver-remote-area-of-canada-2016-7
What was all that blabbing from the sidelines about a pullback. They should have just bought and continue buying. No brainer here
Nice. Good catch. Good moves. Happy happy happy
No update from silver slayer! Figured it would have predicted this movement?
Not sure. Don't see the same action on CCM. Usually they go together. Now CRCUF is same price. Odd behavior